Indications for cholesterol-lowering medication: comparison of risk-assessment methods

This publication has 15 references indexed in Scilit:

• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials
  The Lancet, 1996
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Lipid-Lowering for Prevention of Coronary Heart Disease: What Policy Now?
  Clinical Science, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Prevention of coronary heart disease in clinical practice
  European Heart Journal, 1994
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Cholesterol lowering and mortality: the importance of considering initial level of risk.
  BMJ, 1993
• Mismatch of coronary risk and treatment intensity under the national cholesterol education program guidelines
  Journal of General Internal Medicine, 1991
• Screening for total cholesterol. Do the National Cholesterol Education Program's recommendations detect individuals at high risk of coronary heart disease?
  Circulation, 1991